This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Omega Healthcare Investors (OHI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Omega Healthcare Investors (OHI) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 7.25% and 4.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Are Finance Stocks Lagging Crescent Capital BDC (CCAP) This Year?
by Zacks Equity Research
Here is how Crescent Capital BDC (CCAP) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
Key Reasons to Add Welltower (WELL) to Your Portfolio Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens, strategic portfolio-repositioning efforts and a healthy balance sheet imply an optimistic near-term scenario for Welltower (WELL).
Here's Why Ventas (VTR) is an Apt Pick for Your Portfolio
by Zacks Equity Research
A rise in healthcare spending by senior citizens, accretive investments in the R&I business and office segment, and a solid balance sheet imply an optimistic near-term scenario for Ventas (VTR).
Host Hotels (HST) Gains 12% in 3 Months: Will the Trend Last?
by Zacks Equity Research
Healthy operating performance amid improving demand, capital-recycling efforts and a robust balance sheet position are likely to continue driving Host Hotels' (HST) stock in the near term.
Omega Healthcare Investors (OHI) Q1 FFO Surpass Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 10% and 0.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Corporate Office Properties (OFC) Surpasses Q1 FFO Estimates
by Zacks Equity Research
Corporate Office Properties (OFC) delivered FFO and revenue surprises of 3.51% and 4.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Alpine Income (PINE) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Alpine Income (PINE) delivered FFO and revenue surprises of -5.26% and 5.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $27.26 in the latest trading session, marking a +0.81% move from the prior day.
Omega Healthcare Investors (OHI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $27.61, moving +0.77% from the previous trading session.
Omega Healthcare Investors (OHI) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Q4 FFO Match Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 0% and 6.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare (OHI) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Rent defaults by some of Omega Healthcare's (OHI) operators facing occupancy and elevated staffing cost pressure, and the firm's restructuring moves might have adversely impacted its Q4 earnings.
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $29.06 in the latest trading session, marking a +1.43% move from the prior day.
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KBWY
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Omega Healthcare Investors (OHI) Q3 FFO and Revenues Lag Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of -1.30% and 4.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Omega Healthcare (OHI) in Q3 Earnings?
by Zacks Equity Research
Omega Healthcare's (OHI) Q3 results are likely to reflect the nonpayment of the rent by some operators, low occupancy and elevated costs.
Medical Properties (MPW) Matches Q3 FFO Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0% and 9.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KBWY
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $30.65 in the latest trading session, marking a +0.96% move from the prior day.
Omega Healthcare Investors (OHI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $30.36, moving +1.27% from the previous trading session.
Omega Healthcare Investors (OHI) Stock Moves -0.43%: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $30.27, moving -0.43% from the previous trading session.
Omega Healthcare Investors (OHI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $29.57, moving +0.48% from the previous trading session.